Dr. Markus Templin

After completing his doctorate at the University of Tübingen in 1994, he started working as a scientist at the NMI in 2000 and has been group leader of the Assay Development group since 2003. His research interests include cellular signal transduction, antibody-based proteomics, and protein analysis and method development.

Selected publications

• A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun., 2016, DOI: 10.1038/ncomms12852
• A high-throughput pipeline for validation of antibodies. Nat Methods, 2018, DOI: 10.1038/s41592-018-0179-8
• Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2. ACS Infect Dis., 2021, DOI: 10.1021/acsinfecdis.0c00725
• Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome. Cancers, 2022, DOI: 10.3390/cancers14184542
• Characterization of hepatic zonation in mice by mass-spectrometric and antibody-based proteomics approaches. Biol Chem, 2022, DOI: 10.1515/hsz-2021-0314

ORCID: 0000-0002-6569-6489